Skip to main content

Alterity Therapeutics Limited - American Depositary Shares (NQ:ATHE)

3.540 -0.030 (-0.84%)
Streaming Delayed Price Updated: 3:18 PM EST, Feb 10, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 4,284
Open 3.480
Bid (Size) 3.470 (1,000)
Ask (Size) 3.590 (100)
Prev. Close 3.570
Today's Range 3.480 - 3.570
52wk Range 2.521 - 7.000
Shares Outstanding 2,084,016,678
Dividend Yield N/A

Performance

YTD
+12.0%
+12.0%
1 Month
+0.6%
+0.6%
3 Month
-5.5%
-5.5%
6 Month
-33.5%
-33.5%
1 Year
-23.4%
-23.4%

More News

Read More

Frequently Asked Questions

Is Alterity Therapeutics Limited - American Depositary Shares publicly traded?
Yes, Alterity Therapeutics Limited - American Depositary Shares is publicly traded.
What exchange does Alterity Therapeutics Limited - American Depositary Shares trade on?
Alterity Therapeutics Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alterity Therapeutics Limited - American Depositary Shares?
The ticker symbol for Alterity Therapeutics Limited - American Depositary Shares is ATHE on the Nasdaq Stock Market
What is the current price of Alterity Therapeutics Limited - American Depositary Shares?
The current price of Alterity Therapeutics Limited - American Depositary Shares is 3.540
When was Alterity Therapeutics Limited - American Depositary Shares last traded?
The last trade of Alterity Therapeutics Limited - American Depositary Shares was at 02/10/26 03:18 PM ET
What is the market capitalization of Alterity Therapeutics Limited - American Depositary Shares?
The market capitalization of Alterity Therapeutics Limited - American Depositary Shares is 7.38B
How many shares of Alterity Therapeutics Limited - American Depositary Shares are outstanding?
Alterity Therapeutics Limited - American Depositary Shares has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.